Btr Capital Management Inc Abb Vie Inc. Transaction History

Btr Capital Management Inc

$641 Million
Q3 2022

A detailed history of Btr Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Btr Capital Management Inc holds 17,765 shares of ABBV stock, worth $3.25 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

17,765

Previous 17,865 0.56%

Holding current value

$3.25 Million

Previous $2.74 Million 12.87%

% of portfolio

0.37%

Previous 0.39%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	SELL	$134.21 - $153.93 $13,421 - $15,393	-100 Reduced 0.56%	17,765 $2.38 Million
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $216,476 - $275,212	-1,573 Reduced 8.09%	17,865 $2.74 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $29,959 - $37,171	-227 Reduced 1.15%	19,438 $3.15 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $149,864 - $189,622	1,395 Added 7.64%	19,665 $2.66 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $9,576 - $10,870	-90 Reduced 0.49%	18,270 $1.97 Million
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $149,713 - $166,789	1,423 Added 8.4%	18,360 $2.07 Million
Q1 2021 Apr 08, 2021	SELL	$102.3 - $112.62 $56,265 - $61,941	-550 Reduced 3.15%	16,937 $1.83 Million
Q4 2020 Jan 12, 2021	BUY	$80.49 - $108.67 $85,158 - $114,972	1,058 Added 6.44%	17,487 $1.87 Million
Q3 2020 Oct 15, 2020	SELL	$85.91 - $100.83 $137,198 - $161,025	-1,597 Reduced 8.86%	16,429 $1.44 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $18,342 - $24,545	250 Added 1.41%	18,026 $1.77 Million
Q1 2020 Apr 21, 2020	SELL	$64.5 - $97.79 $159,121 - $241,247	-2,467 Reduced 12.19%	17,776 $1.35 Million
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $2,519 - $3,028	-40 Reduced 0.2%	20,243 $1.53 Million
Q2 2019 Jul 18, 2019	SELL	$65.7 - $83.98 $92,308 - $117,991	-1,405 Reduced 6.48%	20,283 $1.48 Million
Q1 2019 Apr 04, 2019	SELL	$77.14 - $90.79 $115,324 - $135,731	-1,495 Reduced 6.45%	21,688 $0
Q4 2018 Jan 23, 2019	SELL	$77.85 - $96.01 $165,042 - $203,541	-2,120 Reduced 8.38%	23,183 $2.14 Million
Q3 2018 Oct 04, 2018	BUY	$88.91 - $98.84 $124,474 - $138,376	1,400 Added 5.86%	25,303 $2.39 Million
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $52,521 - $62,144	-585 Reduced 2.39%	23,903 $2.22 Million
Q1 2018 May 01, 2018	BUY	$92.01 - $123.21 $166,538 - $223,010	1,810 Added 7.98%	24,488 $2.32 Million
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $26,688 - $29,266	-298 Reduced 1.3%	22,678 $2.19 Million
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $1.6 Million - $2.05 Million	22,976	22,976 $2.04 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Btr Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Btr Capital Management Inc with notifications on news.

Account

Btr Capital Management Inc Abb Vie Inc. Transaction History